As one of the selected startups for the NEOTEC 2024 program, PlaBiTe will develop an innovative project entitled “Development of Platelet-Based Bioproducts for Use in Cell Culture and Regenerative Medicine.” This project is set to commence in 2025 and will play a crucial role in the company’s growth.
The NEOTEC program aims to support the creation and consolidation of technology-based companies, focusing on projects that require proprietary technology grounded in research and innovation.
This recognition is particularly significant for us, as it reinforces our commitment to developing innovative technologies in the field of biomedicine.
